Loading
A phase 3 trial of fOLFIRI (5-FU, leucovorin, irinotecan) and fOLFOX (5-FU, leucovorin, oxaliplatin) in colorectal cancer, run by Uppsala University, now recruiting.
Efficacy of Hyperthermic Intraperitoneal Chemotherapy is a phase 3, randomised interventional study registered as NCT04861558 by Uppsala University, with a registry enrolment figure of 213 participants, started 2021-05-01 and due to reach its primary completion in 2025-12. Interventions recorded: 5Fluorouracil; Irinotecan; Oxaliplatin. Conditions listed: Colorectal Cancer; Peritoneal Metastases. Primary outcome: Recurrence-free survival. Colorectal eligibility wording from the registry: "Colorectal cancer with peritoneal metastases +/- liver metastases (maximum 3)". Sites: India, Sweden. No results are recorded here; the registry entry is the source.
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares HIPEC / PIPAC (intraperitoneal chemotherapy), FOLFOX (5-FU, leucovorin, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.